The Effect of High Flow Oxygen Therapy Via Tracheostomy on Diaphragm Function

Sponsor
Evangelismos Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04758910
Collaborator
(none)
30
2
5

Study Details

Study Description

Brief Summary

While the high flow oxygen therapy (HFOT) respiratory support system, delivered through nasal cannulas, has demonstrated clinical benefits on respiratory function, limited data exist on whether such effects are also present in HFOT through tracheostomy. Therefore, the aim of the proposed study is to examine the short-term effects of HFOT as opposed to oxygen therapy via T-piece on diaphragmatic function in tracheostomized patients with prolonged weaning from mechanical ventilation.

Condition or Disease Intervention/Treatment Phase
  • Device: High Flow Oxygen Therapy
  • Device: T-piece
N/A

Detailed Description

Critically ill patients who experience difficulties in weaning from the ventilator often undergo tracheostomy. These patients usually undergo spontaneous breathing trials receiving oxygen via T-piece. While the high flow oxygen therapy (HFOT) respiratory support system, delivered through nasal cannulas, has demonstrated clinical benefits on respiratory function, limited data exist on whether such effects are also present in HFOT through tracheostomy. Therefore, we plan to perform a study to examine the short-term effects of HFOT on diaphragmatic function in tracheostomized patients with prolonged weaning from mechanical ventilation.

After disconnection from the ventilator, patients will undergo a 30-minute spontaneous breathing trial receiving oxygen either conventionally via T-piece, or by HFOT delivered via tracheostomy, followed by a washout period of 15 min breathing through T-piece and 30 min receiving oxygen with the other modality in a randomized manner. At the start and end of each study period, patients will undergo an assessment through diaphragm ultrasonography, which includes excursion of diaphragmatic dome and thickness of diaphragmatic zone of apposition at end-inspiration and end-expiration. Subsequently, the diaphragmatic thickening fraction will be calculated as the difference between end-inspiratory and end-expiratory thickness divided by end-expiratory thickness. Also. arterial blood gases as well as respiratory rate (RR) and tidal volume (TV) (through a Wright's spirometer) will be measured.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Participants will receive two treatments : high flow oxygen therapy and T-piece.Participants will receive two treatments : high flow oxygen therapy and T-piece.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of High Flow Oxygen Therapy Via Tracheostomy on Diaphragm Function in Patients With Prolonged Weaning From Mechanical Ventilation
Anticipated Study Start Date :
Mar 1, 2021
Anticipated Primary Completion Date :
May 30, 2021
Anticipated Study Completion Date :
Jul 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: High Flow Oxygen Therapy

Tracheostomized patients will undergo a spontaneous breathing trial with high flow oxygen therapy.

Device: High Flow Oxygen Therapy
A 30-minute spontaneous breathing trial using high flow oxygen therapy via tracheostomy.

Active Comparator: T-piece

Tracheostomized patients will undergo a spontaneous breathing trial with T-piece as a standard of care.

Device: T-piece
A 30-minute spontaneous breathing trial using T-piece via tracheostomy.
Other Names:
  • Standard of care
  • Outcome Measures

    Primary Outcome Measures

    1. Diaphragmatic function [30 minutes]

      Differences in diaphragmatic function between high flow oxygen therapy and T-piece will be assessed by diaphragm excursion measurement (in cm) using bedside ultrasound examination of the diaphragm.

    2. Diaphragmatic thickening fraction [30 minutes]

      Differences in diaphragmatic thickening fraction between high flow oxygen therapy and T-piece will be assessed using bedside ultrasound examination of the diaphragm thickness of diaphragmatic zone of apposition at end-inspiration and end-expiration and subsequent calculation of the difference between end-inspiratory and end-expiratory thickness divided by end-expiratory thickness.

    Secondary Outcome Measures

    1. Tidal volume [30 minutes]

      Differences in tidal volume between high flow oxygen therapy and T-piece will be assessed by tidal volume (in mL) measurement by a Wright's spirometer.

    2. Respiratory frequence [30 minutes]

      Differences in respiratory frequency between high flow oxygen therapy and T-piece will be assessed by respiratory rate measurement (breaths per minute).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Mechanically ventilated patients with prolonged weaning and tracheostomy
    Exclusion Criteria:
    • pregnancy

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Evangelismos Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    CHRISTINA ROUTSI, Professor in Medicine, National and Kapodistrian University of Athens, Athens, Greece, Evangelismos Hospital
    ClinicalTrials.gov Identifier:
    NCT04758910
    Other Study ID Numbers:
    • No 771 2019
    First Posted:
    Feb 17, 2021
    Last Update Posted:
    Feb 17, 2021
    Last Verified:
    Feb 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by CHRISTINA ROUTSI, Professor in Medicine, National and Kapodistrian University of Athens, Athens, Greece, Evangelismos Hospital

    Study Results

    No Results Posted as of Feb 17, 2021